NCT02918019 A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma Status COMPLETED Phase PHASE2
NCT02915224 A Study of Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and Comorbidities Status COMPLETED Phase N/A
NCT02913482 Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy Status COMPLETED Phase PHASE2
NCT02913456 A European Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced (LA) or Metastatic Breast Cancer (mBC) (SAMANTHA) Status COMPLETED Phase N/A
NCT02913443 A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC) Status COMPLETED Phase PHASE1
NCT02908685 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants Status COMPLETED Phase PHASE2
NCT02908672 A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma Status COMPLETED Phase PHASE3
NCT02901431 A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD) Status TERMINATED Phase PHASE2
NCT02896855 A Study to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel Versus Placebo + Trastuzumab + Docetaxel in Previously Untreated Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT02892318 A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE1
NCT02891824 ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab Status COMPLETED Phase PHASE3
NCT02882009 A Study to Assess the Impact of Speed and Site of Subcutaneous Injection on Pain, Tolerability, Safety, and Pharmacokinetics of Gantenerumab in Healthy Participants Status COMPLETED Phase PHASE1
NCT02879981 A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis Status COMPLETED Phase N/A
NCT02876224 Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Status COMPLETED Phase PHASE1
NCT02864199 A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment Status COMPLETED Phase PHASE4
NCT02861014 A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) Status COMPLETED Phase PHASE3
NCT02850289 APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin Status COMPLETED Phase N/A
NCT02847637 A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors Status COMPLETED Phase PHASE3
NCT02846428 To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer Status COMPLETED Phase PHASE2